BMRA - BIOMERICA INC
2.18
0.020 0.917%
Share volume: 10,376
Last Updated: 04-22-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$2.16
0.02
0.01%
View ratios
| Fiscal Date | 02-29-2024 | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 08-31-2025 | 11-30-2025 | 02-28-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
| Report Date | 04-12-2024 | 01-14-2025 | 10-15-2024 | 01-14-2025 | 04-14-2025 | 10-14-2025 | 01-14-2026 | 04-13-2026 | |
| Total revenue | 1.017 M | 1.118 M | 1.807 M | 1.636 M | 1.119 M | 1.380 M | 1.210 M | 987.000 K | |
| Cost of revenue | 1.166 M | 1.095 M | 1.518 M | 1.199 M | 1.100 M | 956.000 K | 1.159 M | 1.031 M | |
| Gross profit | -149.000 K | 23.000 K | 289.000 K | 437.000 K | 19.000 K | 424.000 K | 51.000 K | -44.000 K | |
| 115.44% | 1,156.52% | 51.21% | -95.65% | 2,131.58% | -87.97% | -186.27% | |||
| Operating expenses | 1.851 M | 1.550 M | 1.657 M | 1.430 M | 1.229 M | 1.542 M | 1.424 M | 1.254 M | |
| Selling general and admin | 1.508 M | 1.286 M | 1.360 M | 1.173 M | 1.012 M | 1.330 M | 1.231 M | 1.076 M | |
| Research and development | 343.000 K | 264.000 K | 297.000 K | 257.000 K | 217.000 K | 212.000 K | 193.000 K | 178.000 K | |
| Total expenses | 1.851 M | 1.550 M | 1.657 M | 1.430 M | 1.229 M | 1.542 M | 1.424 M | 1.254 M | |
| -16.26% | 6.90% | -13.70% | -14.06% | 25.47% | -7.65% | -11.94% | |||
| Operating income | -2.000 M | -1.527 M | -1.368 M | -993.000 K | -1.210 M | -1.118 M | -1.373 M | -1.298 M | |
| Ebit | -2.000 M | -1.527 M | -1.368 M | -993.000 K | -1.210 M | -1.118 M | -1.373 M | -1.304 M | |
| Pretax income | -1.914 M | -1.414 M | -1.312 M | -953.000 K | -1.167 M | 5.000 K | -1.315 M | -1.304 M | |
| -26.12% | -7.21% | -27.36% | 22.46% | -100.43% | -26,400.00% | -0.84% | |||
| Income tax | 4.000 K | 7.000 K | 4.000 K | -3.000 K | -4.000 K | 3.000 K | 5.000 K | 8.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -1.918 M | -1.421 M | -1.316 M | -950.000 K | -1.163 M | 2.000 K | -1.320 M | -1.312 M | |
| 25.91% | 7.39% | 27.81% | -22.42% | 100.17% | -66,100.00% | 0.61% |